26-Item Advanced Women’s Health Screening Package in China

1. Thyroid Ultrasound — Reviews the thyroid for structural findings such as cysts or nodules.
2. Carotid Arteries Ultrasound — Reviews carotid artery structure and blood flow for findings that may need clinical follow-up.
3. Liver, Gallbladder, Spleen and Pancreas Ultrasound — Reviews the morphology of the upper-abdominal organs and may identify findings such as stones inflammation or masses.
4. Bilateral Kidneys, Bladder and Ureters Ultrasound — Reviews the urinary system for findings such as stones inflammatory change hydronephrosis or space-occupying lesions.
5. Uterus and Adnexes / Vaginal route Ultrasound — Assesses the uterus ovaries and adnexal structures; the final examination route depends on individual suitability.
6. Breast and Peripheral Lymph Nodes Ultrasound — Reviews breast tissue and regional lymph nodes for findings that may require further assessment.

7. Routine Gynecological Examination — Provides a clinician-led examination of gynecological structures and visible findings.
8. Routine Vaginal Discharge Examination — Assesses a vaginal discharge sample for findings that may be associated with infection or inflammation.
9. Pap Smear: Human Papillomavirus (HPV) 23 Subtypes Detection — Tests the cervical sample for 23 source-listed HPV subtypes as part of cervical screening.
10. Pap Smear: TCT Cervical Smear — Uses thin-layer cytology to assess cervical cells for changes that may require follow-up.

11. Alpha-Fetoprotein (AFP) — Measures AFP as a quantitative tumor-related marker interpreted with the wider clinical picture.
12. Carcinoembryonic Antigen (CEA) — Measures CEA as a quantitative tumor-related marker interpreted with other findings.
13. Carbohydrate Antigen CA19-9 — Measures CA19-9 as a quantitative tumor-related marker interpreted in clinical context.
14. Carbohydrate Antigen-CA125 — Measures CA125 as a quantitative tumor-related marker interpreted in clinical context.
15. Carbohydrate Antigen CA15-3 — Measures CA15-3 as a quantitative tumor-related marker interpreted in clinical context.

16. Liver Function 5 Items — Provides a source-listed laboratory profile of selected liver-related indicators.
17. Thyroid Function 3 Items — Measures three source-listed thyroid-function indicators.
18. Renal Function 3 Items — Measures three source-listed kidney-function indicators.
19. Fasting Blood Glucose — Measures blood glucose after the confirmed fasting preparation.
20. Glycated Hemoglobin — Provides an estimate of average glucose exposure over the preceding months.
21. Blood Lipid 4 Items — Measures four source-listed blood-lipid indicators relevant to cardiovascular risk assessment.
22. Cardiac Function 4 Items — Measures four source-listed cardiac-related laboratory indicators.
23. Cell Blood Count (CBC) — Measures blood-cell counts and related parameters for a general hematology profile.
24. Urinalysis — Reviews urine parameters for findings that may require clinical interpretation.

25. Chest CT Scan Contrast free — Provides non-contrast chest imaging for structural review of the lungs and thorax.
26. Imaging Electrocardiogram (ECG) — Records resting cardiac electrical activity and rhythm for clinical interpretation.

No. Quantitative tumor markers are one part of a wider screening picture and require professional interpretation with history and other findings.

No. The gynecological examination and uterus/adnexa or vaginal-route ultrasound are confirmed individually after suitability review.

No. It is a screening and coordination package. If a finding needs attention, appropriate follow-up may be recommended.

The coordination team provides confirmed fasting, medication and scheduling instructions after reviewing the inquiry.